Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
Background: Kidney transplantation is the treatment of choice for patients with end-stage renal disease. Objective: To evaluate the changes in serum soluble TNF-like weak inducer of apoptosis (sTWEAK) and fibroblast growth factor 23 (FGF-23) in hemodialysis (HD) patients and renal transplant recipi...
Main Authors: | H Eskandari Naji, A Ghorbanihaghjo, H Argani, S Raeisi, J Safa, AH Alirezaei, N Rashtchizadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2017-04-01
|
Series: | International Journal of Organ Transplantation Medicine |
Subjects: | |
Online Access: | http://www.ijotm.com/ojs/index.php/IJOTM/article/view/338 |
Similar Items
-
The Diagnostic Value of sTWEAK in Acute Ischemic Stroke
by: Ertan Comertpay, et al.
Published: (2020-11-01) -
Comparison of the outcomes of laparoscopic pyeloplasty with and without concomitant pyelolithotomy
by: Mustafa Kadihasanoglu, et al.
Published: (2019-11-01) -
Local tissue reaction and histopathological characteristics of three different bulking agents: a rabbit model
by: Shabnam Sabetkish, et al.
Published: (2021-02-01) -
The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction
by: Ramón Iglesias-Rey, et al.
Published: (2022-03-01) -
PDE5 Inhibitor Treatment Persistence and Adherence in Brazilian Men: Post-hoc Analyses from a 6-Month, Prospective, Observational Study
by: Carlos Cairoli, et al.
Published: (2014-06-01)